Olema Pharmaceuticals Stock Performance
| OLMA Stock | USD 8.70 0.35 4.19% |
Olema Pharmaceuticals holds a performance score of 11 on a scale of zero to a hundred. The company holds a Beta of 0.52, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Olema Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Olema Pharmaceuticals is expected to be smaller as well. Use Olema Pharmaceuticals information ratio, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance , to analyze future returns on Olema Pharmaceuticals.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Olema Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Olema Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 4.19 | Five Day Return 8.75 | Year To Date Return 56.19 | Ten Year Return (82.24) | All Time Return (82.24) |
1 | Does Olema Pharmaceuticals Inc. qualify in momentum factor screening - Rate Hike High Yield Equity Trading Tips - Newser | 08/26/2025 |
2 | Disposition of 1914 shares by Cyrus Harmon of Olema Pharmaceuticals at 8.08 subject to Rule 16b-3 | 09/16/2025 |
3 | What analysts say about Olema Pharmaceuticals Inc stock - Analyst Upgrades Low Cost Portfolio Ideas - earlytimes.in | 10/07/2025 |
4 | Guggenheim Initiates Olema Pharmaceuticals Coverage with Buy Rating and 20 PT, Cites Palazestrant Potential | 10/16/2025 |
5 | HC Wainwright Co. Reiterates Buy Rating for Olema Pharmaceuticals OLMA Stock News - GuruFocus | 10/20/2025 |
6 | FNY Investment Advisers LLC Has 42,000 Stock Holdings in Olema Pharmaceuticals, Inc. OLMA | 10/24/2025 |
7 | Why Olema Pharmaceuticals Inc. stock is in analyst buy zone - 2025 Market Sentiment Free Real-Time Market Sentiment Alerts - newser.com | 10/27/2025 |
8 | Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here | 10/30/2025 |
9 | Can Olema Pharmaceuticals Inc. stock double in next 5 years - Earnings Growth Report Free Fast Gain Swing Trade Alerts - newser.com | 11/03/2025 |
10 | Olema Pharmaceuticals GAAP EPS of -0.49 | 11/10/2025 |
| Begin Period Cash Flow | 68.5 M | |
| Total Cashflows From Investing Activities | -93.5 M |
Olema Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 527.00 in Olema Pharmaceuticals on August 13, 2025 and sell it today you would earn a total of 343.00 from holding Olema Pharmaceuticals or generate 65.09% return on investment over 90 days. Olema Pharmaceuticals is currently generating 1.0022% in daily expected returns and assumes 6.6468% risk (volatility on return distribution) over the 90 days horizon. In different words, 59% of stocks are less volatile than Olema, and 80% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Olema Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Olema Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Olema Pharmaceuticals, and traders can use it to determine the average amount a Olema Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1508
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OLMA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.65 actual daily | 59 59% of assets are less volatile |
Expected Return
| 1.0 actual daily | 20 80% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Olema Pharmaceuticals is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Olema Pharmaceuticals by adding it to a well-diversified portfolio.
Olema Pharmaceuticals Fundamentals Growth
Olema Stock prices reflect investors' perceptions of the future prospects and financial health of Olema Pharmaceuticals, and Olema Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Olema Stock performance.
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.3 | ||||
| Current Valuation | 407.43 M | ||||
| Shares Outstanding | 68.63 M | ||||
| Price To Book | 2.21 X | ||||
| EBITDA | (129.08 M) | ||||
| Net Income | (129.47 M) | ||||
| Cash And Equivalents | 240.71 M | ||||
| Cash Per Share | 6.01 X | ||||
| Total Debt | 1.43 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 19.75 X | ||||
| Book Value Per Share | 5.03 X | ||||
| Cash Flow From Operations | (104.35 M) | ||||
| Earnings Per Share | (1.97) X | ||||
| Market Capitalization | 573.1 M | ||||
| Total Asset | 450.98 M | ||||
| Retained Earnings | (435.11 M) | ||||
| Working Capital | 396.71 M | ||||
About Olema Pharmaceuticals Performance
By analyzing Olema Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Olema Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Olema Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Olema Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.29) | (0.30) | |
| Return On Capital Employed | (0.35) | (0.33) | |
| Return On Assets | (0.29) | (0.30) | |
| Return On Equity | (0.32) | (0.30) |
Things to note about Olema Pharmaceuticals performance evaluation
Checking the ongoing alerts about Olema Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Olema Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Olema Pharmaceuticals is way too risky over 90 days horizon | |
| Olema Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Olema Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (129.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Olema Pharmaceuticals currently holds about 240.71 M in cash with (104.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.01. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Olema Pharmaceuticals GAAP EPS of -0.49 |
- Analyzing Olema Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Olema Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Olema Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Olema Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Olema Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Olema Pharmaceuticals' stock. These opinions can provide insight into Olema Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Olema Stock analysis
When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |